Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
11.50 -0.02 / -0.17%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.50 0.00 / 0.00%
 
Volume: 20.8K

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Nektar Therapeutics have a median target of 16.00, with a high estimate of 19.00 and a low estimate of 9.00. The median estimate represents a +39.13% increase from the last price of 11.50.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Nektar Therapeutics. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$33.8M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -223.50%
 
 
 
 
 
 
Growthannually -26.19%
 
 
 
 
 
 

Sales

Growthquarterly -68.93%
 
 
 
 
 
 
Growthannually 16.09%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account